Johnny Page, MS

Johnny Page is a Co-Founder and CEO of Bolden Therapeutics. He received his A.B. in Music, Sc.B. in Neuroscience, and Sc.M. in Biotechnology, all from Brown University. He has completed two years of medical school at Alpert Medical School. Johnny has also completed additional entrepreneurship training as part of the I-Corps Spark Program at MIT. Johnny leads Bolden’s effort to develop novel compounds to help treat neurological diseases.